Literature DB >> 57940

Collagenase inhibitors: rationale for their use in treating corneal ulceration.

.   

Abstract

Tissue collagenases have been implicated in corneal ulceration in human corneal disease and in ulceration of the rabbit cornea that has served as a model system. Such enzymes from the rabbit and human cornea are inhibited by metal-binding agents of the EDTA type, by thiols, and by the human serum antiprotease alpha2-macroglobulin. Determination of the relative efficacies of collagenase inhibitors indicates that EDTA and Ca-EDTA are about one hundred times more effective on a molar basis than L-cysteine and its derivatives, N-acetyl-L-cysteine and D-penicillamine. The alpha2-macroglobulin on a molar basis, is superior as an inhibitor to the metal-binding agents and thiols. Although Ca may be a necessary cofactor of the corneal collagenases, such a requirement has not been established unequivocally. Inhibition and isotope studies do indicate a requirement for Zn. Thiols are thought to inhibit corneal collagenases by binding to or removing an intrinsic metal cofactor (Zn), and/or possibly by reducing one or more disulfide bonds. Inhibition by both EDTA-type agents and thiols is largely reversible by dialysis. The human alpha2-macroglobulin appears to inhibit corneal colleagenases irreversibly by forming tight complexes with them. Ca-EDTA, cysteine, and acetylcysteine, given as eyedrops, are able to prevent or retard ulceration in the alkali-burned rabbit cornea. They appear to have some efficacy in the prevention of corneal ulceration in humans. EDTA-type compounds are quite stable under routine storage, while acetylcysteine is more stable than cysteine. EDTA is quite toxic and should not be used as eye medication. Ca-EDTA has a low toxicity, and cysteine and acetylcysteine have even lower toxicity. It is not yet certain which inhibitor has the most favorable therapeutic index for clinical use, or is the optimal mode of drug delivery known. However, the collagenase inhibitors seem to have therapeutic promise in the prevention of corneal ulceration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 57940     DOI: 10.1097/00004397-197501540-00006

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  10 in total

1.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

Review 2.  Inflammatory mechanisms in corneal ulceration.

Authors:  K R Kenyon
Journal:  Trans Am Ophthalmol Soc       Date:  1985

3.  Enzymatic activity of beta-N-acetylglucosaminidase in the alkali-burned rabbit cornea.

Authors:  V Chayakul; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

4.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.

Authors:  A C Poon; G Geerling; J K Dart; G E Fraenkel; J T Daniels
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

5.  Corneal collagen cross-linking and liposomal amphotericin B combination therapy for fungal keratitis in rabbits.

Authors:  Zhao-Qin Hao; Jin-Xin Song; Shi-Yin Pan; Lin Zhang; Yan Cheng; Xian-Ning Liu; Jie Wu; Xiang-Hua Xiao; Wei Gao; Hai-Feng Zhu
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

6.  Use of a hyperdried cross-linked amniotic membrane as initial therapy for corneal perforations.

Authors:  Kiyotaka Kitagawa; Motonori Okabe; Shuichiro Yanagisawa; Xue-Yun Zhang; Toshio Nikaido; Atsushi Hayashi
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

7.  Corneal cross-linking in 9 horses with ulcerative keratitis.

Authors:  Anna Hellander-Edman; Karim Makdoumi; Jes Mortensen; Björn Ekesten
Journal:  BMC Vet Res       Date:  2013-06-26       Impact factor: 2.741

8.  Development and characterization of a rapid polymerizing collagen for soft tissue augmentation.

Authors:  Dale Devore; Jiaxun Zhu; Robert Brooks; Rebecca Rone McCrate; David A Grant; Sheila A Grant
Journal:  J Biomed Mater Res A       Date:  2015-12-18       Impact factor: 4.396

9.  Various cross-linking methods inhibit the collagenase I degradation of rabbit scleral tissue.

Authors:  Konstantin Krasselt; Cornelius Frommelt; Robert Brunner; Franziska Georgia Rauscher; Mike Francke; Nicole Körber
Journal:  BMC Ophthalmol       Date:  2020-12-14       Impact factor: 2.209

10.  Effects of N-acetylcysteine on matrix metalloproteinase-9 secretion and cell migration of human corneal epithelial cells.

Authors:  T Ramaesh; K Ramaesh; S C Riley; J D West; B Dhillon
Journal:  Eye (Lond)       Date:  2012-07-06       Impact factor: 3.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.